An observational study in Microbiota, sponsored by First Affiliated Hospital of Harbin Medical University. Status unknown at 1 site in China. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-27.
Sponsored by First Affiliated Hospital of Harbin Medical University · Observational
Autoimmune thyroiditis (AITD) mainly includes Hashimoto's thyroiditis (HT) and Grave's disease (GD). Studies have shown that autoimmune thyroiditis is closely related to microbial disorders such as autoimmune thyroiditis However, there is no report on the relationship between oral microecology and autoimmune thyroiditis. Therefore, our group will study the correlation between oral microbiota and AITD.
Autoimmune thyroiditis (AITD) mainly includes Hashimoto's thyroiditis (HT) and Grave's disease (GD). Studies have shown that autoimmune thyroiditis is closely related to microbiological disorders. Intestinal microelements Both ecology and oral microecology belong to the category of microorganisms. It has been reported in the literature that intestinal microecology occurs disorder of autoimmune thyroiditis. However, there is no report on the correlation between oral microecology and autoimmune thyroiditis. When oral microbe flora When the immune system is disrupted, the immune balance is broken, the immune system is over-active, and the autoimmune disease (AID) is lost to the autoantigens and non-pathogenic commensal microbial flora antigens, including rheumatoid arthritis, Sjogren's syndrome, systemic lupus erythematosus, inflammatory bowel disease, and allergic diseases. However, the association between oral microbial flora and AITD remains unclear. . Therefore, the research group will carry out the correlation between oral microbial flora and AITD.
All patients were included according to the inclusion and exclusion criteria
Exclusion Criteria:
30 healthy volunteers were included in the healthy control group
30 GD patients who received treatment with Methimazole Pill or propylthiouracil pill
Drug: Methimazole Pill · Drug: Propylthiouracil Pill
30 untreated GD patients
30 HT patients
Patients who developed GD received methimazole treatment
Patients who developed GD received propylthiouracil treatment
Transcriptional changes in oral microbiota
The microbiota measured by 16S rRNA gene
Time frame: Baseline, 3 months, 6 months, 9 months, 12 months
Serum thyroid function changed
Serum thyroid function measured by Immunohistochemistry
Time frame: Baseline, 3 months, 6 months, 9 months, 12 months
Serum thyroid related antibodies changed
Serum thyroid related antibodies measured by Immunohistochemistry
Time frame: Baseline, 3 months, 6 months, 9 months, 12 months
Plan to share: No
This study is status unknown, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
First Affiliated Hospital of Harbin Medical University